- Home
- General Medicine And Specialty Medicine Industry
- Neurology Research Reports, January 2013 (p4)
Top countries
Publication dates
Publishers
All regions
-
- Australia (6)
- Austria (2)
- Belgium (2)
- Canada (5)
- Chile (1)
- Czech Republic (2)
- Denmark (2)
- Finland (1)
- France (9)
- Germany (9)
- Greece (1)
- Hungary (1)
- Ireland (2)
- Israel (4)
- Italy (4)
- Japan (7)
- Mexico (4)
- Netherlands (2)
- New Zealand (2)
- Norway (1)
- Poland (1)
- Portugal (1)
- South Korea (3)
- Spain (4)
- Sweden (2)
- Switzerland (3)
- Turkey (1)
- United Kingdom (4)
- United States (28)
data types
Neurology Research Reports, January 2013 (p4)
You might be interested in: medical equipment, interventional neurology, nucleic acid testing, more »
31-40 of about 100 reports for Neurology
The Credentialing and Privileges Manual (4th edition, 2013)
- $ 550
- Industry report
- January 2013
- by Apollo Managed Care Consultants
426 pages of credentialing policies, procedures, peer evaluation strategies and detailed privilege lists + criteria to grant privileges for each physician specialty as well as other licensed health care ...
- Industries : General Medicine and Specialty Medicine
NeuroWave Systems Inc. - Product Pipeline Analysis
- $ 750
- Company report
- December 2012
- by Global Data
Summary NeuroWave Systems Inc. (NeuroWave) is a medical device company. The company develops, manufacture and markets monitoring products using advanced signal processing of brain waves and other bio signals ...
- Industries : General Medicine and Specialty Medicine
Neurology - Pipeline Review, H2 2012
- $ 2 500
- Company report
- December 2012
- by Global Markets Direct
Neurology - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Neurology - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information ...
- Industries : General Medicine and Specialty Medicine
- Countries : World
Competitor Analysis: Toll-like Receptor (TLR) Agonists & Antagonists
- $ 903
- Industry report
- December 2012
- by La Merie Publishing
Product description The Competitive Intelligence Report Toll-Like Receptor (TLR) Agonists & Antagonists provides a competitor analysis in the development pipeline of novel small molecules, proteins, DNA, ...
- Industries : General Medicine and Specialty Medicine
Societe Adwya SA: Company Capsule
- $ 99
- Company report
- November 2012
- by Canadean Ltd
Synopsis Canadean's "Societe Adwya SA - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products ...
- Industries : General Medicine and Specialty Medicine
- Countries : Tunisia
Parkway Holdings Limited (Symbol:P27) SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
Parkway Holdings Limited (Parkway) is a Singapore based healthcare company. The company offers a diverse range of services like management of medical clinics, care and related services, clinical research ...
- Industries : General Medicine and Specialty Medicine
- Countries : Singapore
Luye Pharma Group Co., Ltd. (Symbol:A61) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : General Medicine and Specialty Medicine
- Countries : Singapore, South Korea
Eisai Inc. SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : General Medicine and Specialty Medicine
- Countries : United States
Merz Pharma GmbH & Co. KgaA - Strategic SWOT Analysis Review
- $ 125
- Company report
- November 2012
- by Global Data
Summary Merz Pharma GmbH & Co. KgaA (Merz Pharma) is a Germany-based pharmaceutical company. The company focuses on research and development of drugs for the treatment of illnesses in the fields of neurology, ...
- Industries : General Medicine and Specialty Medicine
- Countries : Germany
The Magstim Company Limited SWOT Analysis, Strategy, Revenues and Profits
- $ 125
- Company report
- November 2012
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : General Medicine and Specialty Medicine
- Countries : United States, France, Germany, Japan
» Download Public Reports
About 1 000 reports for Neurology
Neurological Disease Industry Overview
- Industry report
- November 2012
- 20 pages
U.s. Neurological Disease Sector Brief
February 2012» Read our Company Profiles
16 Companies for NeurologyIntegra LifeSciences Holdings Corp.
United StatesBoston Scientific Corp.
United StatesB Braun Melsungen AG
GermanyMedtronic Inc.
United StatesNihon Kohden Corp.
JapanReportlinker.com © Copyright 2013. All rights reserved.
